Advanced imaging technology detects undiagnosed metastases in high-risk prostate cancer

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Risk Adjusted Net Present Value: What is the current valuation of 180 Life Sciences’s Fibrosis and anti-TNF

The revenue for Fibrosis and anti-TNF is expected to reach an annual total of $140 mn by 2037 globally based off GlobalData’s Expiry Model. The

August 28, 2023

Taiho outlays $1.14bn to acquire ADC specialist Araris – Pharmaceutical Technology

There have been several high-profile deals between big pharma companies and ADC specialists in recent years. Image credit: Shutterstock/ afry_harvy. Taiho Pharmaceutical has agreed to

March 17, 2025

Biomarker found in urine could help diagnose acute tubulointerstitial nephritis

In a study led by Johns Hopkins Medicine, in collaboration with Yale School of Medicine, researchers have identified a biomarker found via a simple urine

July 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.